Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| LVLBV26_05 | LVLBV26_05 | Gabon | 2000 | HIV1 | G | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | None | NA |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| A98G | K20R, V35T, T39E, E40D, V60I, K104R, V106I, V118I, D123S, I135V, K173A, Q174K, D177E, T200A, Q207E, R211K, F214L, V245Q, E248D, D250E, S251I, A272P, Q278H, K281R, T286A, E291D, V292I, I293V, P294T, E297T, L301M, P321Q, D324E, I329V, Q334L, G335D, F346Y, R356K, M357K, R358G, G359S, A371V, S379G, T386V, K390R, Q394R, A400V |
| >LVLBV26_05| codons 1-428 PISPIETVPVKLKPGMDGPRVKQWPLTEEKIKALTEICEDMEKEGKISKIGPENPYNTPI FAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPGGLKKKRSITVLDVGDAYFSIPL DKSFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRAKNPEIVI YQYMDDLYVGSDLEIGQHRAKIEELREHLLKWGLTTPDKKHQKEPPFLWMGYELHPDKWT VQPIQLPDKEIWTVNDIQKLVGKLNWASQIYPGIKVKHLCRLLRGAKALTDIVTLTTEAE MELAENREILKEPVHGVYYDQSKELIAEVQKQGLDQWTYQIYQEPYKNLKTGKYAKKGSA HTNDVKQLTEVVQKIATEGIVIWGKVPKFRLPIRKETWEVWWTEYWQATWIPEWEFVNTP PLVKLWYQ |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| I13V, K20I, M36I, R41K, C67S, H69R, V82I, L89M |
| >LVLBV26_05| codons 1-99 PQITLWQRPLVTVKIGGQLIEALLDTGADDTVLEEINLPGKWKPKMIGGIGGFIKVRQYD QILIEISGRKAIGTVLVGPTPINIIGRNMLTQIGCTLNF |
References
| Author | Title | Citation |
| Vergne, L | Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries. | JAIDS, 2002 |